Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: nevodka / Shutterstock.com 23andMe (NASDAQ: ME ) is preparing for a major change at the executive level. Today, the firm announced that CFO Steven Schoch is planning to resign . Schoch had held the r...
The shares of genetics testing company 23andMe Holding Co. ( NASDAQ: ME ) dropped ~8% in the pre-market trading Friday after the company announced the resignation of its Chief Financial Officer Steven Schoch, effective Sep. 01. Citing a letter from Mr. Schoch on Aug. 1...
Two new Breakout Stocks for Week 33 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +115.9% YTD. This week two picks beat 10% gains in less than week with SELB +34.5% and LYFT +16.2% at peak gains and next top gains in ASIX...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: nevodka / Shutterstock.com Shares of 23andMe (NASDAQ: ME ) stock are all over the map today. This is a continuing theme for the month; ME stock has exploded over the past nine trading sessions. From the ...
While it's a relatively quiet day for the Nasdaq Composite (NASDAQINDEX: ^IXIC) itself today, there's a lot of volatility within its component stocks. As of 1:23 p.m. ET on Aug. 11, the stock index is up a modest 0.25%. That's good enough to keep it up more than 20% from the rec...
23andMe ( NASDAQ: ME ) stock fell ~14% premarket Aug. 9 after the company's Q1 net loss widened Y/Y due to higher operating expenses. Q1 FY23 total revenue grew ~9% Y/Y to $64.51M. The company said the increase was mainly due to inclusion of a full quarter o...
CorMedix CRMD -61% after FDA again rejects CorMedix's application for lead candidate DefenCath . Turtle Beach HEAR -32% on Q2 earnings miss . Novavax NVAX -31% on Q2 earnings release . Medicenna Therapeutics MDNA -29% on launch of units offeri...
23andMe Holding Co. (ME) Q1 2023 Earnings Conference Call August 08, 2022 04:30 PM ET Company Participants Wade Walke - Vice President, Investor Relations Anne Wojcicki - Chief Executive Officer & Co-Founder Steve Schoch - Chief Financial Officer Kenneth ...
23andMe press release ( NASDAQ: ME ): Q1 GAAP EPS of -$0.20. Revenue of $64.5M (+8.9% Y/Y). Shares -3.3% . FY2023 Financial Guidance23andme reconfirmed its full year guidance following Q1 FY2023 results. Full year revenue for fiscal 2023, which will end on Marc...
First quarter revenue grew 9% to $64.5 million Consumer revenue grew 17% year over year due to the addition of telehealth revenue On track to achieve FY2023 financial guidance SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME)...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lun...